


<!DOCTYPE html>
<html lang="en">
<head><script src="//archive.org/includes/analytics.js?v=cf34f82" type="text/javascript"></script>
<script type="text/javascript">window.addEventListener('DOMContentLoaded',function(){var v=archive_analytics.values;v.service='wb';v.server_name='wwwb-app17.us.archive.org';v.server_ms=2237;archive_analytics.send_pageview({});});</script><script type="text/javascript" src="/static/js/wbhack.js?v=1531166943.0" charset="utf-8"></script>

<script type="text/javascript">
__wbhack.init('https://web.archive.org/web');
</script>
<link rel="stylesheet" type="text/css" href="/static/css/banner-styles.css?v=1531166943.0" />
<link rel="stylesheet" type="text/css" href="/static/css/iconochive.css?v=1531166943.0" />

<!-- End Wayback Rewrite JS Include -->  

        <title>Second-trimester abortion. | National Guideline Clearinghouse</title>

    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width">
    <link rel="icon" href="/web/20180712210219im_/https://www.guideline.gov/UI/images/favicon-NGC.ico">
    <link rel="apple-touch-icon" sizes="180x180" href="/web/20180712210219im_/https://www.guideline.gov/UI/images/apple-touch-icon-NGC.png">
    <link rel="icon" type="image/png" href="/web/20180712210219im_/https://www.guideline.gov/UI/images/favicon-NGC-32x32.png" sizes="32x32">
    <link rel="icon" type="image/png" href="/web/20180712210219im_/https://www.guideline.gov/UI/images/favicon-NGC-16x16.png" sizes="16x16">
    <link rel="manifest" href="/web/20180712210219/https://www.guideline.gov/UI/images/manifest-NGC.json">
    <link rel="mask-icon" href="/web/20180712210219im_/https://www.guideline.gov/UI/images/safari-pinned-tab-NGC.svg" color="#1d4345">
    <meta name="theme-color" content="#ffffff">
    
<link href="/web/20180712210219cs_/https://www.guideline.gov/cassette.axd/stylesheet/8382974d7bae1577062376dcd37102348398fe04/NGCSiteCSS" type="text/css" rel="stylesheet"/>
<!--[if lt IE 9]>
<link href="/cassette.axd/stylesheet/2188ac5b8507764bb4079068f7a3c8d7ccfba0e7/ieCSS" type="text/css" rel="stylesheet"/>
<![endif]-->



    <script async type="text/javascript" id="_fed_an_ua_tag" src="https://web.archive.org/web/20180712210219js_/https://dap.digitalgov.gov/Universal­-Federated-­Analytics-­Min.js?agency=HHS&amp;subagency=AHRQ"></script>
    </head>
<body class="no-js content-page">
<a href="#main-content" id="skip-nav">Skip to main content</a>
<!--https://developers.google.com/tag-manager/devguide#multidomain  ECH-1199-->
    
    <!-- Google Tag Manager -->
    <noscript>
        <iframe src="//web.archive.org/web/20180712210219if_/https://www.googletagmanager.com/ns.html?id=GTM-W4NX5V" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712210219/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-W4NX5V');</script>

    <noscript>
        <iframe src="//web.archive.org/web/20180712210219if_/https://www.googletagmanager.com/ns.html?id=GTM-KHDP6Z" height="0" width="0" style="display:none;visibility:hidden"></iframe>
    </noscript>
    <script>
        (function (w, d, s, l, i) {
            w[l] = w[l] || []; w[l].push({
                'gtm.start':
                new Date().getTime(), event: 'gtm.js'
            }); var f = d.getElementsByTagName(s)[0],
            j = d.createElement(s), dl = l != 'dataLayer' ? '&l=' + l : ''; j.async = true; j.src =
            '//web.archive.org/web/20180712210219/https://www.googletagmanager.com/gtm.js?id=' + i + dl; f.parentNode.insertBefore(j, f);
        })(window, document, 'script', 'dataLayer', 'GTM-KHDP6Z');</script>
    <!-- End Google Tag Manager -->


    <!-- AHRQ HEADER -->
<div id="ahrq-header">

	<p class="hhs-links">
		<a href="https://web.archive.org/web/20180712210219/http://www.hhs.gov/" target="_blank" class="logo-hhs"><span class="logomark"></span>U.S.&nbsp;Department of&nbsp;Health&nbsp;and Human&nbsp;Services</a>
		<a href="https://web.archive.org/web/20180712210219/http://www.hhs.gov/" target="_blank" class="external-link"><strong>HHS.gov</strong></a>
	</p><!-- /.hhs-links -->
	<p class="ahrq-links">
		<a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/" target="_blank" class="logo-ahrq">Agency for Healthcare Research and Quality: Advancing Excellence in Health Care</a>
		<a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/" target="_blank" class="external-link"><strong>AHRQ.gov</strong></a>
	</p><!-- /.ahrq-links -->

</div><!-- /#ahrq-header -->

	<!-- HEADER -->
	<div class="header" id="header">
		<div class="masthead">

			<ul class="header-actions">
				<li><a href="#header-search" class="search-action"><span class="label">Search</span></a></li>
				<li><a href="#header-account" class="account-action"><span class="label">Account</span></a></li>
				<li><a href="#main-nav" class="menu-action"><span class="label">Menu</span></a></li>
			</ul><!-- /.header-actions -->
				
				<a href="/web/20180712210219/https://www.guideline.gov/" class="header-logo NGC">
				    <picture>
				        <source media="(min-width: 960px)" srcset="/web/20180712210219im_/https://www.guideline.gov/UI/images/logo_NGC_header.png">
				        <source srcset="/web/20180712210219im_/https://www.guideline.gov/UI/images/logo_NGC_header_m.png">
				        <img src="/web/20180712210219im_/https://www.guideline.gov/UI/images/logo_NGC_header.png" alt="National Guideline Clearinghouse">
				    </picture>
				</a>
<form action="/web/20180712210219/https://www.guideline.gov/search" class="header-search header-action" enctype="multipart/form-data" id="header-search" method="get">					<p class="search-bar">
						<label for="q"><span class="screen-reader-text">Search</span>
							<input id="q" type="text" title="Search Input" name="q" class="search-input" placeholder="Search">
						</label>
						<input id="masthead-search-button" type="submit" title="Search Submit" class="search-submit" value="Search">
					</p>
					<p class="search-tips">
						<a href="/web/20180712210219/https://www.guideline.gov/help-and-about/search-browse/search-tips">Search Tips</a>
					</p>
</form>				<div class="header-account header-action" id="header-account">
				<a id="login-button" class="signin" href="/web/20180712210219/https://www.guideline.gov/accounts/signinlanding" aria-role="tab" aria-controls="login-panel" aria-selected="false">Log into My NGC</a>
<div id="login-panel" class="login dropdown" aria-role="tab-panel" aria-labeledby="login-button" aria-hidden="true">
    
            <div class="sign-in">
            <form id="sign-in-form" action="/web/20180712210219/https://www.guideline.gov/Accounts/LoginSubmit" method="post">
                <h3>Sign In</h3>
                <div class="errormessages"></div>
                <p class="invalid-user-cred message-block" style="display: none;"></p>
                <p>
                    <label for="sign-in-username">Username or Email <span class="required">*</span></label>
                    <input type="text" id="sign-in-username" class="input-text" name="email" required>
                   
                </p>
                <p>
                    <label for="sign-in-userpwd">Password <span class="required">*</span></label>
                    <input type="password" id="sign-in-userpwd" class="input-text" name="password" required>
                  
                </p>
                <p class="form-link"><a href="/web/20180712210219/https://www.guideline.gov/accounts/forgotpassword">Forgot Password?</a></p>
                <p><label for="remember-me"><input type="checkbox" name="remember-me" id="remember-me">Remember Me</label></p>
                <input id="account-sign-in" type="submit" value="Sign In"/>
            </form>
            <p>
                <label for="sign-up-btn">Don't have an account?</label>
                <a href="/web/20180712210219/https://www.guideline.gov/accounts/login" class="sign-up-btn" id="sign-up-btn">Create New Account</a>
            </p>
        </div><!--/.sign-in-->
</div><!-- /.login -->
				</div><!-- /.header-account -->
		</div><!-- /.masthead -->

		<div class="main-nav header-action" id="main-nav">
		    <ul class="level-1">
		        <li class=""><a href="/web/20180712210219/https://www.guideline.gov/">Home</a></li>
		        <li class=""><a href="/web/20180712210219/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
		        <li>
<a href="/web/20180712210219/https://www.guideline.gov/summaries/browse" class="parent-link">Guideline Summaries</a>                    		            <ul class="level-2 dropdown">
                             <li class=""><a href="/web/20180712210219/https://www.guideline.gov/browse/clinical-specialty">By Clinical Specialty</a></li>
		                <li class=""><a href="/web/20180712210219/https://www.guideline.gov/browse/organization">By Organization</a></li>
		                <li class=""><a href="/web/20180712210219/https://www.guideline.gov/browse/mesh-tag">By MeSH Tag</a></li>
		                <li class=""><a href="/web/20180712210219/https://www.guideline.gov/summaries/in-progress">In Progress</a></li>
		                <li class=""><a href="/web/20180712210219/https://www.guideline.gov/summaries/archive">Archive</a></li>

		                <li class=""><a href="/web/20180712210219/https://www.guideline.gov/search?f_DocType=0&amp;fLockTerm=Guideline Summaries">All Summaries</a></li>
		            </ul>
		        </li>
<li class=""><a href="/web/20180712210219/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>		        <li class=""><a href="/web/20180712210219/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		        <li class=""><a href="/web/20180712210219/https://www.guideline.gov/matrix">Matrix Tool</a></li>
		        <li class="">
<a href="/web/20180712210219/https://www.guideline.gov/summaries/submit">Submit Guidelines</a>                    		        </li>
                <li class=""><a href="/web/20180712210219/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>		      
		    </ul>
		</div><!-- /.main-nav -->
</div><!-- /.header -->

    <br/><div class="content"><div class="fundingNotice2"><b>The AHRQ National Guideline Clearinghouse (NGC, guideline.gov) Web site will not be available after July 16, 2018</b> because federal funding <br/>through AHRQ will no longer be available to support the NGC as of that date. For additional information, read our <a href="/web/20180712210219/https://www.guideline.gov/home/announcements">full announcement</a>.</div></div>

	<!-- CONTENT -->
	<main id="main-content" tabindex="-1">
		

<div class="main">

		<div class="aside-container">

	<div class="content">

    <!-- CONTENT HEADER -->
    <div class="content-header">
        <ul class="content-header-meta">
            <li class="prefix-icon guideline">Guideline Summary</li>
            <li>NGC:009900</li>
            <li>2013 Jun
            </li>            
                                </ul>
        <div>
                <h1>Second-trimester abortion.</h1>
        </div>
    </div>
    <!-- /.content-header-meta -->

        <!-- CONTENT TABS -->
        <ul class="content-tabs">
            <li><a href="#developer-tab" class="developer is-active"><span class="label">Developer</span></a></li>
            <li><a href="#source-tab" class="source"><span class="label">Source</span></a></li>
            <li><a href="#status-tab" class="status"><span class="label">Status</span></a></li>
            <li><a href="#classification-tab" class="classification"><span class="label">Classification</span></a></li>
        </ul>
        <div id="developer-tab" class="is-active content-tab-panel">
                <ul class="developer-list">
        <li><a href="/web/20180712210219/https://www.guideline.gov/search?f_Guideline_Developer_String=American%20College%20of%20Obstetricians%20and%20Gynecologists&amp;fLockTerm=American%2BCollege%2Bof%2BObstetricians%2Band%2BGynecologists">American College of Obstetricians and Gynecologists</a></li>
                        <li>   
                                <a id="85" href="#" data-alert="SignInLanding" data-alert-type="organization" class="get-alerts get-org-alerts">Get Alerts</a>
                        </li>
                </ul>
        </div>
    <!-- /.content-tab-panel -->
    <div id="source-tab" class="content-tab-panel">
<table><tr><td>American College of Obstetricians and Gynecologists (ACOG). Second-trimester abortion. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2013 Jun. 13 p.&nbsp;(ACOG practice bulletin; no. 135).&nbsp; [106 references]</td></tr></table>            </div>
    <!-- /.content-tab-panel -->
    <div id="status-tab" class="content-tab-panel">
            <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
    </div>
    <!-- /.content-tab-panel -->
    <div id="classification-tab" class="content-tab-panel">


        
                    <h4>Age Group</h4>
            <ul>
                        <li><a href="/web/20180712210219/https://www.guideline.gov/search?f_Age_of_Target_Population=Adolescent%20%2813%20to%2018%20years%29&amp;fLockTerm=Adolescent%2B%2813%2Bto%2B18%2Byears%29">Adolescent (13 to 18 years)</a></li>                      
                        <li><a href="/web/20180712210219/https://www.guideline.gov/search?f_Age_of_Target_Population=Adult%20%2819%20to%2044%20years%29&amp;fLockTerm=Adult%2B%2819%2Bto%2B44%2Byears%29">Adult (19 to 44 years)</a></li>                      
            </ul>
                    <h4>UMLS Concepts <a href="/web/20180712210219/https://www.guideline.gov/help-and-about/search-browse/umls-concepts" class="what-is">(what is this?)</a></h4>
                <div class="field">
                    <h5 class="field-label">MSH</h5>
                    <div class="field-content">
<a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0392535&amp;fLockTerm=Abortion%2c+Induced">Abortion, Induced</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0000812&amp;fLockTerm=Abortion%2c+Legal">Abortion, Legal</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0000820&amp;fLockTerm=Abortion%2c+Therapeutic">Abortion, Therapeutic</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0012358&amp;fLockTerm=Dilatation+and+Curettage">Dilatation and Curettage</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0013631&amp;fLockTerm=Education%2c+Medical">Education, Medical</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0021794&amp;fLockTerm=Internship+and+Residency">Internship and Residency</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0026088&amp;fLockTerm=Mifepristone">Mifepristone</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0085174&amp;fLockTerm=Misoprostol">Misoprostol</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0032962&amp;fLockTerm=Pregnancy+Complications">Pregnancy Complications</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0032976&amp;fLockTerm=Pregnancy+Tests">Pregnancy Tests</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0032980&amp;fLockTerm=Pregnancy+Trimester%2c+Second">Pregnancy Trimester, Second</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0032995&amp;fLockTerm=Pregnancy%2c+Unwanted">Pregnancy, Unwanted</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0033052&amp;fLockTerm=Prenatal+Care">Prenatal Care</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0042413&amp;fLockTerm=Vasopressins">Vasopressins</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MSH_CUI=C0043212&amp;fLockTerm=Women%27s+Health+Services">Women&#39;s Health Services</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">MTH</h5>
                    <div class="field-content">
<a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0201849&amp;fLockTerm=Antidiuretic+hormone+measurement">Antidiuretic hormone measurement</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0179804&amp;fLockTerm=CATHETER%2c+FOLEY">CATHETER, FOLEY</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0012358&amp;fLockTerm=Dilatation+and+Curettage">Dilatation and Curettage</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0392535&amp;fLockTerm=Induced+abortion+(procedure)">Induced abortion (procedure)</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0000812&amp;fLockTerm=Legal+abortion+(procedure)">Legal abortion (procedure)</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0032962&amp;fLockTerm=Pregnancy+Complications">Pregnancy Complications</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0032976&amp;fLockTerm=Pregnancy+Tests">Pregnancy Tests</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0033052&amp;fLockTerm=Prenatal+care">Prenatal care</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0000820&amp;fLockTerm=Therapeutic+abortion+(procedure)">Therapeutic abortion (procedure)</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0156543&amp;fLockTerm=Unspecified+Abortion">Unspecified Abortion</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0032995&amp;fLockTerm=Unwanted+pregnancy">Unwanted pregnancy</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_MTH_CUI=C0042413&amp;fLockTerm=Vasopressins">Vasopressins</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">PDQ</h5>
                    <div class="field-content">
<a href="/web/20180712210219/https://www.guideline.gov/search?f_PDQ_CUI=C0026088&amp;fLockTerm=mifepristone">mifepristone</a>
, <a href="/web/20180712210219/https://www.guideline.gov/search?f_PDQ_CUI=C0085174&amp;fLockTerm=misoprostol">misoprostol</a>
                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">SNOMEDCT_US</h5>
                    <div class="field-content">
<a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0033052&amp;fLockTerm=Antenatal+care">Antenatal care</a>
 (424525001), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0201849&amp;fLockTerm=Antidiuretic+hormone+measurement">Antidiuretic hormone measurement</a>
 (61966007), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0012358&amp;fLockTerm=Dilation+and+curettage+of+uterus">Dilation and curettage of uterus</a>
 (11401008), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0012358&amp;fLockTerm=Dilation+and+curettage+of+uterus">Dilation and curettage of uterus</a>
 (13091001), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0559233&amp;fLockTerm=Evacuation+of+uterus">Evacuation of uterus</a>
 (275166002), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C3472682&amp;fLockTerm=Insufficient+prenatal+care">Insufficient prenatal care</a>
 (1031000119109), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0181374&amp;fLockTerm=Intrauterine+balloon">Intrauterine balloon</a>
 (469477007), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0289432&amp;fLockTerm=Methylergonovine+maleate">Methylergonovine maleate</a>
 (126075009), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0289432&amp;fLockTerm=Methylergonovine+maleate">Methylergonovine maleate</a>
 (52412009), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026088&amp;fLockTerm=Mifepristone">Mifepristone</a>
 (129483007), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0026088&amp;fLockTerm=Mifepristone">Mifepristone</a>
 (395796009), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0085174&amp;fLockTerm=Misoprostol">Misoprostol</a>
 (387242007), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0085174&amp;fLockTerm=Misoprostol">Misoprostol</a>
 (43684009), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032961&amp;fLockTerm=Pregnancy">Pregnancy</a>
 (289908002), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032976&amp;fLockTerm=Pregnancy+detection+examination">Pregnancy detection examination</a>
 (74036000), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0156543&amp;fLockTerm=Pregnancy+with+abortive+outcome">Pregnancy with abortive outcome</a>
 (363681007), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032980&amp;fLockTerm=Second+trimester+pregnancy">Second trimester pregnancy</a>
 (255247007), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032980&amp;fLockTerm=Second+trimester+pregnancy">Second trimester pregnancy</a>
 (59466002), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0392535&amp;fLockTerm=Termination+of+pregnancy">Termination of pregnancy</a>
 (386639001), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0000820&amp;fLockTerm=Therapeutic+termination+of+pregnancy+procedure">Therapeutic termination of pregnancy procedure</a>
 (386641000), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0032995&amp;fLockTerm=Unwanted+pregnancy">Unwanted pregnancy</a>
 (58532003), <a href="/web/20180712210219/https://www.guideline.gov/search?f_SNOMEDCT_US_CUI=C0043212&amp;fLockTerm=Women%27s+health+service">Women&#39;s health service</a>
 (2651000175101)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
                <div class="field">
                    <h5 class="field-label">UMD</h5>
                    <div class="field-content">
<a href="/web/20180712210219/https://www.guideline.gov/search?f_UMD_CUI=C0179804&amp;fLockTerm=Catheters%2c+Urinary%2c+Urethral%2c+Drainage%2c+Self-Retained">Catheters, Urinary, Urethral, Drainage, Self-Retained</a>
 (10-720), <a href="/web/20180712210219/https://www.guideline.gov/search?f_UMD_CUI=C0181374&amp;fLockTerm=Intrauterine+Balloons">Intrauterine Balloons</a>
 (12-155)                    </div>
                    <!-- /.field-content -->
                </div>
                <!-- /.field -->
    </div>
        <!-- /.content-tab-panel -->
        <!-- /.content-tab-panel -->
        <!-- TOOLBAR -->
        <div class="content-toolbar">

            <!-- Primary -->
            <ul class="tools primary-tools">
                <li class="dropdown tool sections">
                    <a href="#" class="tool-button">Sections</a>
                    <div class="dropdown-panel">
                            <ul class="section-links">
                                    <li><a href="#420" class="section-mark">Recommendations</a></li>
                                    <li><a href="#396" class="section-mark">Scope</a></li>
                                    <li><a href="#405" class="section-mark">Methodology</a></li>
                                    <li><a href="#424" class="section-mark">Evidence Supporting the Recommendations</a></li>
                                    <li><a href="#427" class="section-mark">Benefits/Harms of Implementing the Guideline Recommendations</a></li>
                                    <li><a href="#432" class="section-mark">Qualifying Statements</a></li>
                                    <li><a href="#434" class="section-mark">Implementation of the Guideline</a></li>
                                    <li><a href="#439" class="section-mark">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></li>
                                    <li><a href="#442" class="section-mark">Identifying Information and Availability</a></li>
                                    <li><a href="#99999" class="section-mark">Disclaimer</a></li>
                            </ul>    
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
            </ul>

            <!-- Other -->
            <ul class="tools other-tools">
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Download</a>

                    <div class="dropdown-panel">
                        <ul>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/downloadcontent/ngc-9900?contentType=pdf" class="pdf">.PDF 86.2 kb</a></li>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/downloadcontent/ngc-9900?contentType=word" class="word">Word Document 279.1 kb</a></li>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/downloadcontent/ngc-9900?contentType=xml" class="xml">.XML 29.7 kb</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Share</a>
                    <div class="dropdown-panel">
                        <ul class="toolbar-social">
                            <li><a target="_blank" href="https://web.archive.org/web/20180712210219/https://www.facebook.com/sharer/sharer.php?u=https://www.guideline.gov/summaries/summary/46411/secondtrimester-abortion" class="facebook">Facebook</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712210219/https://twitter.com/share?text=&amp;url=https://www.guideline.gov/summaries/summary/46411/secondtrimester-abortion" class="twitter">Twitter</a></li>
                            <li><a target="_blank" href="https://web.archive.org/web/20180712210219/https://www.linkedin.com/shareArticle?mini=true&amp;url=https://www.guideline.gov/summaries/summary/46411/secondtrimester-abortion&amp;title=&amp;summary=&amp;source=" class="linkedin">Linkedin</a></li>
                            <li><a href="https://web.archive.org/web/20180712210219/mailto:/?Subject=AHRQ: Second-trimester abortion.&amp;body=https://www.guideline.gov/summaries/summary/46411/secondtrimester-abortion" class="email">Email</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                <li class="dropdown tool">
                    <a href="#" class="tool-button">Cite</a>
                    <div class="dropdown-panel citation">
                        <p class="text-label"><label for="citation">Citation: </label></p>
                        <textarea id="citation">National Guideline Clearinghouse (NGC). Guideline summary: Second-trimester abortion. In: National Guideline Clearinghouse (NGC) [Web site]. Rockville (MD): Agency for Healthcare Research and Quality (AHRQ); 2013 Jun 01. [cited 2018 Jul 12]. Available: https://www.guideline.gov</textarea>                        
                        <p class="text-label">Download citation file: </p>
                        <ul>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/citedownload/46411?format=ris">RIS (Zotero)</a></li>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/citedownload/46411?format=enw">EndNote</a></li>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/citedownload/46411?format=bibtex">BibTex</a></li>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/citedownload/46411?format=txt">Medlars</a></li>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/citedownload/46411?format=ris">ProCite</a></li>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/citedownload/46411">RefWorks</a></li>
                            <li><a href="/web/20180712210219/https://www.guideline.gov/summaries/citedownload/46411?format=ris">Reference Manager</a></li>
                        </ul>
                    </div>
                    <!-- /.dropdown-panel -->
                </li>
                                
                <li class="tool">
                        <a href="#" id="46411" data-alert="SignInLanding" class="tool-button save-link">Save</a>
                </li>
            </ul>

            <!-- Accordion -->
            <ul class="tools accordion-controls">
                <li class="tool"><a href="#" class="expand-all is-disabled" aria-disabled="true"><span class="screen-reader-text">Expand All</span></a></li>
                <li class="tool"><a href="#" class="collapse-all" aria-disabled="false"><span class="screen-reader-text">Collapse All</span></a></li>
            </ul>
        </div>
        <!-- /.toolbar -->


		<!-- ARTICLE -->
		<div class="article" id="article">
			




    <!-- ACCORDION -->
    <div class="accordion-container" role="tablist" multiselectable="true">
                <h2 id="420" class="accordion-title section-420 is-active" role="tab" aria-expanded="true"><a href="#">Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Major Recommendations</a></h3>
                    <p><div class="content_para"><p>The grades of evidence (<strong>I-III</strong>) and levels of recommendations (<strong>A-C</strong>) are defined at the end of the "Major Recommendations" field.</p>
<p><strong>The following recommendations and conclusions are based on good and consistent scientific evidence (Level A)</strong>:</p>
<ul style="list-style-type: disc;">
    <li>Cervical preparation is recommended before dilation and evacuation (D&amp;E) to decrease risk of cervical trauma. </li>
    <li>Mifepristone followed in 24&ndash;48 hours by misoprostol is the most effective regimen for second-trimester medical abortion. </li>
    <li>Misoprostol as a single agent is effective for medical abortion. </li>
    <li>Administration of prophylactic antibiotics decreases the risk of infection after surgical abortion and, therefore, should be provided to all patients undergoing D&amp;E. </li>
    <li>Except for hysteroscopic sterilization, diaphragm, or cervical cap, all forms of contraception can be considered after second-trimester abortion and initiated on the day of the procedure. </li>
</ul>
<p><strong>The following recommendations and conclusions are based on limited or inconsistent scientific evidence (Level B)</strong>:</p>
<ul style="list-style-type: disc;">
    <li>D&amp;E is associated with fewer complications than medical abortion involving misoprostol regimens. </li>
    <li>When there is a suspicion of abnormal placentation, D&amp;E is the preferred abortion method, and preparations should be made for possible hemorrhage by ensuring the procedure is performed at an appropriate facility with accessibility to blood products, interventional radiology, and the capability to perform a hysterectomy if necessary. </li>
    <li>The use of vasopressin in the paracervical block may decrease blood loss from D&amp;E. </li>
    <li>Methylergonovine maleate is an appropriate first-line uterotonic agent unless contraindicated, as in patients with hypertension. Misoprostol is an effective agent in the setting of postabortion hemorrhage, and doses of 800&ndash;1,000 micrograms are recommended. </li>
    <li>If refractory bleeding is thought to be due to atony or lower uterine segment bleeding, a Foley catheter or intrauterine balloon should be inserted to tamponade the endometrial cavity. </li>
    <li>Because the risk of uterine rupture associated with prior cesarean delivery is similar to the risk among women without a prior cesarean delivery, guidelines support the safety of misoprostol specifically and medical abortion generally in women with one prior cesarean delivery. </li>
</ul>
<p><strong>The following recommendations are based primarily on consensus and expert opinion (Level C)</strong>:</p>
<ul style="list-style-type: disc;">
    <li>In order to ensure access to D&amp;E, residency training programs should offer integrated abortion training that includes second-trimester D&amp;E. </li>
    <li>All physicians should facilitate timely referrals for abortion care to reduce delays in accessing services. </li>
    <li>Interventions to improve and facilitate early identification of pregnancy should be encouraged, including efforts to educate women about the signs and symptoms of pregnancy. </li>
</ul>
<p><strong><span style="text-decoration: underline;">Definitions</span></strong>:</p>
<p><strong>Grades of Evidence</strong></p>
<p><strong>I</strong> Evidence obtained from at least one properly designed randomized controlled trial</p>
<p><strong>II-1</strong> Evidence obtained from well-designed controlled trials without randomization</p>
<p><strong>II-2</strong> Evidence obtained from well-designed cohort or case-control analytic studies, preferably from more than one center or research group</p>
<p><strong>II-3</strong> Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.</p>
<p><strong>III</strong> Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees</p>
<p><strong>Levels of Recommendations</strong></p>
<p><strong>Level A</strong> &mdash; Recommendations are based on good and consistent scientific evidence.</p>
<p><strong>Level B</strong> &mdash; Recommendations are based on limited or inconsistent scientific evidence.</p>
<p><strong>Level C</strong> &mdash; Recommendations are based primarily on consensus and expert opinion.</p></div></p>
                        <h3><a href="#">Clinical Algorithm(s)</a></h3>
                    <p><div class="content_para"><p>None provided</p></div></p>

            </div>
                <h2 id="396" class="accordion-title section-396 is-active" role="tab" aria-expanded="true"><a href="#">Scope</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Disease/Condition(s)</a></h3>
                    <p><div class="content_para"><p>Unwanted pregnancy</p></div></p>
                        <h3><a href="#">Guideline Category</a></h3>
                    <p>Management</p>
                    <p>Treatment</p>
                        <h3><a href="#">Clinical Specialty</a></h3>
                    <p>Emergency Medicine</p>
                    <p>Obstetrics and Gynecology</p>
                        <h3><a href="#">Intended Users</a></h3>
                    <p>Physician Assistants</p>
                    <p>Physicians</p>
                        <h3><a href="#">Guideline Objective(s)</a></h3>
                    <p><div class="content_para"><p>To provide evidence-based guidelines for the medical and surgical methods of second-trimester termination as well as for the management of associated complications</p></div></p>
                        <h3><a href="#">Target Population</a></h3>
                    <p><div class="content_para"><p>Women seeking second-trimester abortion for a variety of medical and social reasons, such as:</p>
<ul style="list-style-type: disc;">
    <li>Delayed awareness of pregnancy </li>
    <li>Delayed access to health care or insurance/funding </li>
    <li>Difficulties in locating and traveling to a provider </li>
    <li>Poverty, lower education level, and having multiple disruptive life events </li>
    <li>Detection of major anatomic or genetic anomalies in the second trimester </li>
    <li>Obstetric and medical indications such as preeclampsia and preterm premature rupture of membranes, among other conditions </li>
    <li>Pregnancy failure before 20 weeks of gestation and fetal demise </li>
</ul></div></p>
                        <h3><a href="#">Interventions and Practices Considered</a></h3>
                    <p><ol style="list-style-type: decimal;" start="1">
    <li>Dilation and evacuation (D&amp;E) </li>
    <li>Mifepristone </li>
    <li>Misoprostol </li>
    <li>Prophylactic antibiotics </li>
    <li>Methylergonovine maleate </li>
    <li>Vasopressin </li>
    <li>Foley catheter or intrauterine balloon </li>
    <li>Residency training programs in D&amp;E </li>
    <li>Reducing delays that contribute to second-trimester identification </li>
    <li>Improve and facilitate early identification of pregnancy </li>
</ol></p>
                        <h3><a href="#">Major Outcomes Considered</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Procedural complications, such as uterine perforation, infection, incomplete abortion </li>
    <li>Preservation of fetal anatomy </li>
    <li>Cost-effectiveness </li>
    <li>Surgical benefits and risks </li>
    <li>Maternal morbidity and mortality </li>
</ul></p>

            </div>
                <h2 id="405" class="accordion-title section-405 is-active" role="tab" aria-expanded="true"><a href="#">Methodology</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Methods Used to Collect/Select the Evidence</a></h3>
                    <p>Hand-searches of Published Literature (Primary Sources)</p>
                    <p>Hand-searches of Published Literature (Secondary Sources)</p>
                    <p>Searches of Electronic Databases</p>
                        <h3><a href="#">Description of Methods Used to Collect/Select the Evidence</a></h3>
                    <p><div class="content_para"><p>The MEDLINE database, the Cochrane Library, and the American College of Obstetricians and Gynecologists' own internal resources and documents were used to conduct a literature search to locate relevant articles published between January 1990 to November 2012. The search was restricted to articles published in the English language. Priority was given to articles reporting results of original research, although review articles and commentaries also were consulted. Abstracts of research presented at symposia and scientific conferences were not considered adequate for inclusion in this document. Guidelines published by organizations or institutions such as the National Institutes of Health and the American College of Obstetricians and Gynecologists were reviewed, and additional studies were located by reviewing bibliographies of identified articles. When reliable research was not available, expert opinions from obstetrician&ndash;gynecologists were used.</p></div></p>
                        <h3><a href="#">Number of Source Documents</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Methods Used to Assess the Quality and Strength of the Evidence</a></h3>
                    <p>Weighting According to a Rating Scheme (Scheme Given)</p>
                        <h3><a href="#">Rating Scheme for the Strength of the Evidence</a></h3>
                    <p><div class="content_para"><p><strong>Grades of Evidence</strong></p>
<p><strong>I</strong> Evidence obtained from at least one properly designed randomized controlled trial</p>
<p><strong>II-1</strong> Evidence obtained from well-designed controlled trials without randomization</p>
<p><strong>II-2</strong> Evidence obtained from well-designed cohort or case&ndash;control analytic studies, preferably from more than one center or research group</p>
<p><strong>II-3</strong> Evidence obtained from multiple time series with or without the intervention. Dramatic results in uncontrolled experiments also could be regarded as this type of evidence.</p>
<p><strong>III</strong> Opinions of respected authorities, based on clinical experience, descriptive studies, or reports of expert committees</p></div></p>
                        <h3><a href="#">Methods Used to Analyze the Evidence</a></h3>
                    <p>Review of Published Meta-Analyses</p>
                    <p>Systematic Review</p>
                        <h3><a href="#">Description of the Methods Used to Analyze the Evidence</a></h3>
                    <p><div class="content_para"><p>Studies were reviewed and evaluated for quality according to the method outlined by the U.S. Preventive Services Task Force. See the "Rating Scheme for the Strength of the Evidence" field.</p></div></p>
                        <h3><a href="#">Methods Used to Formulate the Recommendations</a></h3>
                    <p>Expert Consensus</p>
                        <h3><a href="#">Description of Methods Used to Formulate the Recommendations</a></h3>
                    <p><div class="content_para"><p>Analysis of available evidence was given priority in formulating recommendations. When reliable research was not available, expert opinions from obstetrician-gynecologists were used. See also the "Rating Scheme for the Strength of the Recommendations" field regarding Level C recommendations.</p></div></p>
                        <h3><a href="#">Rating Scheme for the Strength of the Recommendations</a></h3>
                    <p><div class="content_para"><p><strong>Levels of Recommendations</strong></p>
<p><strong>Level A</strong> &mdash; Recommendations are based on good and consistent scientific evidence.</p>
<p><strong>Level B</strong> &mdash; Recommendations are based on limited or inconsistent scientific evidence.</p>
<p><strong>Level C</strong> &mdash; Recommendations are based primarily on consensus and expert opinion.</p></div></p>
                        <h3><a href="#">Cost Analysis</a></h3>
                    <p><div class="content_para"><p>A formal cost analysis was not performed and published cost analyses were not reviewed.</p></div></p>
                        <h3><a href="#">Method of Guideline Validation</a></h3>
                    <p>Internal Peer Review</p>
                        <h3><a href="#">Description of Method of Guideline Validation</a></h3>
                    <p><div class="content_para"><p>Practice Bulletins are validated by two internal clinical review panels composed of practicing obstetrician-gynecologists generalists and sub-specialists. The final guidelines are also reviewed and approved by the American College of Obstetricians and Gynecologists (ACOG) Executive Board.</p></div></p>

            </div>
                <h2 id="424" class="accordion-title section-424 is-active" role="tab" aria-expanded="true"><a href="#">Evidence Supporting the Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Type of Evidence Supporting the Recommendations</a></h3>
                    <p><div class="content_para"><p>The type of supporting evidence is identified and graded for each recommendation (see the "Major Recommendations" field).</p></div></p>

            </div>
                <h2 id="427" class="accordion-title section-427 is-active" role="tab" aria-expanded="true"><a href="#">Benefits/Harms of Implementing the Guideline Recommendations</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Potential Benefits</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>Appropriate provision and management of second-trimester abortion </li>
    <li>Decreased incidence of complications </li>
    <li>Medical abortions involving mifepristone combined with misoprostol have faster times to completion, decreased hospital time, and a lower risk of retained placenta, compared with regimens with misoprostol used alone. </li>
</ul></p>
                        <h3><a href="#">Potential Harms</a></h3>
                    <p><ul style="list-style-type: disc;">
    <li>The mortality rate associated with abortion is low (0.6 per 100,000 legal, induced abortions), and the risk of death associated with childbirth is approximately 14 times higher than that with abortion. </li>
    <li>Rare complications associated with both dilation and evacuation (D&amp;E) and medical abortion include hemorrhage, cervical laceration, retained products of conception, and infection. Uterine perforation can occur with D&amp;E, whereas uterine rupture can occur with medical abortion. </li>
    <li>Other rare complications may include disseminated intravascular coagulation and embolism. </li>
    <li>Adverse events, such as pain and gastrointestinal adverse effects can occur. </li>
</ul></p>

            </div>
                <h2 id="432" class="accordion-title section-432 is-active" role="tab" aria-expanded="true"><a href="#">Qualifying Statements</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Qualifying Statements</a></h3>
                    <p><div class="content_para"><p>The information is designed to aid practitioners in making decisions about appropriate obstetric and gynecologic care. These guidelines should not be construed as dictating an exclusive course of treatment or procedure. Variations in practice may be warranted based on the needs of the individual patient, resources, and limitations unique to the institution or type of practice.</p></div></p>

            </div>
                <h2 id="434" class="accordion-title section-434 is-active" role="tab" aria-expanded="true"><a href="#">Implementation of the Guideline</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Description of Implementation Strategy</a></h3>
                    <p><div class="content_para"><p>An implementation strategy was not provided.</p></div></p>
                        <h3><a href="#">Implementation Tools</a></h3>
                    <p>Foreign Language Translations</p>
                    <p>Patient Resources</p>
                    <p><div class="general-block">For information about availability, see the <i>Availability of Companion Documents</i> and <i>Patient Resources</i> fields below.</div></p>

            </div>
                <h2 id="439" class="accordion-title section-439 is-active" role="tab" aria-expanded="true"><a href="#">Institute of Medicine (IOM) National Healthcare Quality Report Categories</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">IOM Care Need</a></h3>
                    <p>Staying Healthy</p>
                        <h3><a href="#">IOM Domain</a></h3>
                    <p>Effectiveness</p>
                    <p>Patient-centeredness</p>
                    <p>Safety</p>
                    <p>Timeliness </p>

            </div>
                <h2 id="442" class="accordion-title section-442 is-active" role="tab" aria-expanded="true"><a href="#">Identifying Information and Availability</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">Bibliographic Source(s)</a></h3>
                    <p><table><tr><td>American College of Obstetricians and Gynecologists (ACOG). Second-trimester abortion. Washington (DC): American College of Obstetricians and Gynecologists (ACOG); 2013 Jun. 13 p.&nbsp;(ACOG practice bulletin; no. 135).&nbsp; [106 references]</td></tr></table></p>
                        <h3><a href="#">Adaptation</a></h3>
                    <p><div class="content_para"><p>Not applicable: The guideline was not adapted from another source.</p></div></p>
                        <h3><a href="#">Date Released</a></h3>
                    <p>2013 Jun</p>
                        <h3><a href="#">Guideline Developer(s)</a></h3>
                    <p>American College of Obstetricians and Gynecologists - Medical Specialty Society</p>
                        <h3><a href="#">Source(s) of Funding</a></h3>
                    <p><div class="content_para"><p>American College of Obstetricians and Gynecologists (ACOG)</p></div></p>
                        <h3><a href="#">Guideline Committee</a></h3>
                    <p><div class="content_para"><p>American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins&mdash;Gynecology</p></div></p>
                        <h3><a href="#">Composition of Group That Authored the Guideline</a></h3>
                    <p><div class="content_para"><p>This Practice Bulletin was developed by the Committee on Practice Bulletins&mdash;Gynecology with the assistance of Jody Steinauer, MD, Andrea Jackson, MD, and Daniel Grossman, MD.</p>
<p>American College of Obstetricians and Gynecologists (ACOG) committees are created or abolished and their overall function defined by the Executive Board. Appointments are made for one year, with the understanding that such appointment may be continued for a total of three years. The majority of committee members are Fellows, but Junior Fellows also are eligible for appointment. Some committees may have representatives from other organizations when this is particularly appropriate to committee activities. The president elect appoints committee members annually.</p></div></p>
                        <h3><a href="#">Financial Disclosures/Conflicts of Interest</a></h3>
                    <p><div class="content_para"><p>Not stated</p></div></p>
                        <h3><a href="#">Guideline Endorser(s)</a></h3>
                    <p>Society for Maternal-Fetal Medicine - Nonprofit Organization</p>
                    <p>Society of Family Planning - Professional Association</p>
                        <h3><a href="#">Guideline Status</a></h3>
                    <p><div class="content_para"><p>This is the current release of the guideline.</p></div></p>
                        <h3><a href="#">Guideline Availability</a></h3>
                    <p><div class="content_para"><p>No electronic copies available</p>
<p>Print copies: Available for purchase from the American College of Obstetricians and Gynecologists (ACOG) Distribution Center, PO Box 933104, Atlanta, GA 31193-3104; telephone, 800-762-2264; e-mail: <a href="https://web.archive.org/web/20180712210219/mailto:sales@acog.org">sales@acog.org</a>. The ACOG Bookstore is available online at the <a href="/web/20180712210219/https://www.guideline.gov/Home/Disclaimer?id=46411&amp;contentType=summary&amp;redirect=http%3a%2f%2fsales.acog.org%2f" title="ACOG Web site">ACOG Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712210219im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>.</p></div></p>
                        <h3><a href="#">Availability of Companion Documents</a></h3>
                    <p><div class="content_para"><p>None available</p></div></p>
                        <h3><a href="#">Patient Resources</a></h3>
                    <p><div class="content_para"><p>The following is available:</p>
<ul style="list-style-type: disc;">
    <li>Frequently asked questions: Induced abortion. Atlanta (GA): American College of Obstetricians and Gynecologists (ACOG); 2011 Oct. 3 p. Electronic copies: Available in Portable Document Format (PDF) from the <a href="/web/20180712210219/https://www.guideline.gov/Home/Disclaimer?id=46411&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acog.org%2f%7e%2fmedia%2fFor%2520Patients%2ffaq043.pdf%3fdmc%3d1%26ts%3d20130730T1051356044" title="ACOG Web site">American College of Obstetricians and Gynecologists (ACOG) Web site</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712210219im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. Copies are also available in <a href="/web/20180712210219/https://www.guideline.gov/Home/Disclaimer?id=46411&amp;contentType=summary&amp;redirect=http%3a%2f%2fwww.acog.org%2fFor_Patients%2fSearch_Patient_Education_Pamphlets_-_Spanish%2fFiles%2fAborto_provocado" title="ACOG Web site">Spanish</a>&nbsp;<img alt="External Web Site Policy" src="/web/20180712210219im_/https://www.guideline.gov/UI/images/icon_externallink.gif"/>. </li>
</ul>
<p class="Disclaimer">Please note: This patient information is intended to provide health professionals with information to share with their patients to help them better understand their health and their diagnosed disorders. By providing access to this patient information, it is not the intention of NGC to provide specific medical advice for particular patients. Rather we urge patients and their representatives to review this material and then to consult with a licensed health professional for evaluation of treatment options suitable for them as well as for diagnosis and answers to their personal medical questions. This patient information has been derived and prepared from a guideline for health care professionals included on NGC by the authors or publishers of that original guideline. The patient information is not reviewed by NGC to establish whether or not it accurately reflects the original guideline's content.</p></div></p>
                        <h3><a href="#">NGC Status</a></h3>
                    <p><div class="content_para"><p>This summary was completed by ECRI Institute on July 30, 2013.</p></div></p>
                        <h3><a href="#">Copyright Statement</a></h3>
                    <p><div class="content_para"><p>Copyright June 2013 by the American College of Obstetricians and Gynecologists. All rights reserved. No part of this publication may be reproduced, stored in a retrieval system, posted on the Internet, or transmitted, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without prior written permission from the publisher.</p>
<p>Requests for authorization to make photocopies should be directed to Copyright Clearance Center, 222 Rosewood Drive, Danvers, MA 01923, (978) 750-8400.</p></div></p>

            </div>
                <h2 id="99999" class="accordion-title section-99999 is-active" role="tab" aria-expanded="true"><a href="#">Disclaimer</a></h2>
            <div class="accordion-panel is-active" role="tabpanel">
                        <h3><a href="#">NGC Disclaimer</a></h3>
                    <p><p>The National Guideline Clearinghouse™ (NGC) does not develop, produce, approve, or endorse the guidelines represented on this site.</p> 
<p>All guidelines summarized by NGC and hosted on our site are produced under the auspices of medical specialty societies, relevant professional associations, public or private organizations, other government agencies, health care organizations or plans, and similar entities.</p> 
<p>Guidelines represented on the NGC Web site are submitted by guideline developers, and are screened solely to determine that they meet the <a href="/web/20180712210219/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria">NGC Inclusion Criteria</a>.</p> 
<p>NGC, AHRQ, and its contractor ECRI Institute make no warranties concerning the content or clinical efficacy or effectiveness of the clinical practice guidelines and related materials represented on this site. Moreover, the views and opinions of developers or authors of guidelines represented on this site do not necessarily state or reflect those of NGC, AHRQ, or its contractor ECRI Institute, and inclusion or hosting of guidelines in NGC may not be used for advertising or commercial endorsement purposes.</p> 
<p>Readers with questions regarding guideline content are directed to contact the guideline developer.</p></p>

            </div>

    </div>
    <!-- /.accordion-container -->

<!-- ASIDE -->
<!-- FOOTER -->






		</div><!-- /.article -->

	</div><!-- /.content -->

	
			<div class="aside">
				

    <!-- About NGC -->
    <div class="info-block">
            <h3 class="info prefix-icon large-icon">About NGC Guideline Summaries</h3>
            <p>NGC provides structured summaries containing information from clinical practice guidelines.</p>
            <ul>
                <li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/summaries/inclusion-criteria" class="internal-link">Inclusion Criteria</a></li>
                <li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/summaries/template-of-guideline-attributes" class="internal-link">Template of Guideline Attributes</a></li>
                <li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/summaries/classification-scheme" class="internal-link">Classification Scheme</a></li>
            </ul>
            <p><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/summaries/faqs" class="help-button">Guideline Summary FAQs</a></p>

    </div>
    <!-- /info-block -->

    <!-- Guideline Synthesis -->

    <!-- HHS Block -->

    <!-- Related Content -->


    <hr>

    <!-- New on NGC -->
    <div class="subscribe-header">
        <h3 class="subscribe-title">New on NGC</h3>
        <ul class="subscribe-links">
            <li><a href="/web/20180712210219/https://www.guideline.gov/subscribe" class="newsletter"><span class="subscribe-links-label">Get Email Alerts</span></a></li>
            <li><a href="/web/20180712210219/https://www.guideline.gov/rssFiles/ngc_newthisweek.xml" class="rss"><span class="subscribe-links-label">RSS Feed</span></a></li>
        </ul>
    </div>
    <!-- /.subscribe-header -->
        <h5 class="prefix-icon guideline news-list-category-label">Guideline Summaries</h5>
        <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011378</li>
            <li>2017 Oct</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210219/https://www.guideline.gov/summaries/summary/51300/mental-health-care-in-the-perinatal-period-australian-clinical-practice-guideline">Mental health care in the perinatal period: Australian clinical practice guideline.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011372</li>
            <li>2015</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210219/https://www.guideline.gov/summaries/summary/51294/clinical-practice-guideline-on-systemic-lupus-erythematosus">Clinical practice guideline on systemic lupus erythematosus.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011385</li>
            <li>2018 Mar</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210219/https://www.guideline.gov/summaries/summary/51326/vadod-clinical-practice-guideline-for-the-management-of-pregnancy">VA/DoD clinical practice guideline for the management of pregnancy.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011376</li>
            <li>2018 Feb</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210219/https://www.guideline.gov/summaries/summary/51298/clinical-pharmacogenetics-implementation-consortium-cpic-guideline-for-dihydropyrimidine-dehydrogenase-genotype-and-fluoropyrimidine-dosing-2017-update">Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update.</a></p>
    </div>
    <div class="list-item-small">
        <ul class="item-meta">
            <li> NGC:011370</li>
            <li>2017 Dec</li>
        </ul>
       
            <p><a class="" target="" href="/web/20180712210219/https://www.guideline.gov/summaries/summary/51292/the-implementation-of-targeted-temperature-management-an-evidencebased-guideline-from-the-neurocritical-care-society">The implementation of targeted temperature management: an evidence-based guideline from the Neurocritical Care Society.</a></p>
    </div>

    <a class="block-link" href="/web/20180712210219/https://www.guideline.gov/new-this-week/index">
        <h3>New This Week </h3>
        <p>View more and sign up for our Newsletter</p>
    </a>
    <!-- Adobe Reader -->
    <p><a href="/web/20180712210219/https://www.guideline.gov/disclaimer?id=46411&amp;contentType=summary&amp;redirect=http%3A%2F%2Fget.adobe.com%2Freader%2F" class="external-link">Get Adobe Reader</a></p>

			</div><!-- /.aside -->
		</div><!-- /.aside-container -->

	<!-- BACK TO TOP -->
	
	
	



    <!-- COMMENTS -->
    

</div><!-- /.main -->

	</main>

	<!-- FOOTER -->
	<div class="footer" id="footer">

		<div class="footer-grid-container">
			<!-- Header -->
			<div class="footer-header">
				<a href="#" class="footer-logo">
			 		<picture>
					  	<source type="image/svg+xml" srcset="/web/20180712210219im_/https://www.guideline.gov/UI/images/logo_NGC_footer.svg">
					  	<img src="/web/20180712210219im_/https://www.guideline.gov/UI/images/logo_NGC_footer.png" alt="NGC">
					</picture>
				</a>
			</div><!-- /.footer-header -->

			<!-- Content -->
			<div class="footer-content">
				<div class="footer-nav">
					<ul class="level-1">
						<li><a href="/web/20180712210219/https://www.guideline.gov/">Home</a></li>
		                <li><a href="/web/20180712210219/https://www.guideline.gov/new-this-week/index">New This Week</a></li>
						<li><a href="/web/20180712210219/https://www.guideline.gov/browse/organization" class="parent-link">Guideline Summaries</a></li>
<li><a href="/web/20180712210219/https://www.guideline.gov/syntheses/index">Guideline Syntheses</a></li>						<li><a href="/web/20180712210219/https://www.guideline.gov/expert">Expert Commentaries</a></li>
		                <li><a href="/web/20180712210219/https://www.guideline.gov/matrix">Matrix Tool</a></li>
						<li><a href="/web/20180712210219/https://www.guideline.gov/summaries/submit">Submit Guidelines</a></li>
						<li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about">Help &amp;&nbsp;About</a></li>
					</ul>
					<ul class="level-2">
						<li><a href="/web/20180712210219/https://www.guideline.gov/contact-us">Contact Us</a></li>
						<li><a href="/web/20180712210219/https://www.guideline.gov/rss">RSS</a></li>
					    <li><a href="/web/20180712210219/https://www.guideline.gov/site-map">Site Map</a></li>
                        <li><a href="/web/20180712210219/https://www.guideline.gov/browse/related">Related NQMC Measures</a></li>
                        <li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/about/editorial-board">Editorial Board</a></li>
                        <li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/general/web-site-credits">Web Site Credits</a></li>
                        <li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/general/disclaimer">Disclaimer</a></li>
						<li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/general/privacy">Privacy Policy</a></li>
                        <li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/technical/accessibility">Accessibility</a></li>	
                        <li><a href="/web/20180712210219/https://www.guideline.gov/help-and-about/technical/for-web-developers">For Web Developers</a></li>
					</ul>
				</div><!-- /.footer-nav -->
			</div><!-- /.footer-content -->

			<!-- Aside -->
			<div class="footer-aside">
				<h5 class="footer-partner-link-header">Visit our partner sites</h5>
				<ul class="footer-partner-links">
				    <li><!-- NQMC footer link -->
						<a href="https://web.archive.org/web/20180712210219/https://www.qualitymeasures.ahrq.gov/" target="_blank" class="partner-button nqmc">
							<span class="partner-logo">
								<picture>
							    	<source type="image/svg+xml" srcset="/web/20180712210219im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.svg">
									<img src="/web/20180712210219im_/https://www.guideline.gov/UI/images/logo_footerlink_nqmc.png" alt="National Quality Measures Clearinghouse"/>
								</picture>
							</span>
						</a>
					</li><!--/MQMC footer Link -->
					<li><!-- HHS footer link --> 
						<a href="https://web.archive.org/web/20180712210219/https://www.qualitymeasures.ahrq.gov/hhs/index.aspx" target="_blank" class="partner-button hhs">
							<span class="partner-logo">
								<picture>
								    <source type="image/svg+xml" srcset="/web/20180712210219im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.svg">
								    <img src="/web/20180712210219im_/https://www.guideline.gov/UI/images/logo_footerlink_hmis.png" alt="HHS Measures Inventory"/>
								</picture>
							</span>
						</a>
					</li><!--/HHS footer link -->
				</ul>
			</div><!-- /.footer-aside -->

		</div><!-- /.footer-grid-container -->

	</div><!-- /.footer -->

	
	<!-- AHRQ FOOTER -->
	<div id="ahrq-footer">

		<!-- FIRST -->
		<div class="ahrq-first-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<p><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/index.html" class="ahrq-footer-logo" target="_blank">AHRQ</a></p>
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/policy/electronic/accessibility/index.html" target="_blank">Accessibility</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/policy/electronic/disclaimers/index.html" target="_blank">Disclaimers</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/policy/eeo/index.html" target="_blank">EEO</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/policy/foia/index.html" target="_blank">FOIA</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.hhs.gov/web/governance/digital-strategy/index.html" target="_blank">HHS Digital Strategy</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://oig.hhs.gov/" target="_blank">Inspector General</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/policy/electronic/plain-writing/index.html" target="_blank">Plain Writing Act</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/policy/electronic/privacy/index.html" target="_blank">Privacy Policy</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/policy/electronic/about/policyix.html" target="_blank">Electronic Policies</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.hhs.gov/plugins.html" target="_blank">Viewers &amp; Players</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<h3>Get Social</h3>
					<ul class="ahrq-social">
						<li><a href="https://web.archive.org/web/20180712210219/http://www.facebook.com/" target="_blank" class="facebook"><span class="screen-reader-text">Facebook</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.twitter.com/" target="_blank" class="twitter"><span class="screen-reader-text">Twitter</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.linkedin.com/" target="_blank" class="linkedin"><span class="screen-reader-text">LinkedIn</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.youtube.com/" target="_blank" class="youtube"><span class="screen-reader-text">YouTube</span></a></li>
					</ul>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.first-footer -->

		<!-- SECOND -->
		<div class="ahrq-second-footer">
			<div class="column">
			<div class="ahrq-footer-grid-container">
				<div class="ahrq-footer-left">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/index.html" target="_blank" class="ahrq-footer-home-link"><span class="screen-reader-text">AHRQ Home</span></a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/cpi/about/index.html" target="_blank">About Us</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/cpi/about/careers/index.html" target="_blank">Careers</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/contact/index.html" target="_blank">Contact Us</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/Sitemap.html" target="_blank">Sitemap</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/https://info.ahrq.gov/" target="_blank">FAQ</a></li>
					</ul>	
				</div><!-- /.ahrq-footer-left -->
				<div class="ahrq-footer-center">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/health-care-information/index.html" target="_blank">Health Care Information</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/patients-consumers/index.html" target="_blank">For Patients &amp; Consumers</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/professionals/index.html" target="_blank">For Professionals</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/policymakers/index.html" target="_blank">For Policymakers</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/research/index.html" target="_blank">Research Tools &amp; Data</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/funding/index.html" target="_blank">Funding &amp; Grants</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/cpi/index.html" target="_blank">Offices, Centers &amp; Programs</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.ahrq.gov/news/index.html" target="_blank">News &amp; Events</a></li>
					</ul>
				</div><!-- /.ahrq-footer-center -->
				<div class="ahrq-footer-right">
					<ul>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.hhs.gov/" target="_blank">U.S. Department of Health &amp; Human Services</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.whitehouse.gov/" target="_blank">The White House</a></li>
						<li><a href="https://web.archive.org/web/20180712210219/http://www.usa.gov/" target="_blank">USA.gov: The U.S. Government's Official Web Portal   </a></li>
					</ul>
					<p class="ahrq-address">
						<strong>Agency for Healthcare Research&nbsp;and&nbsp;Quality</strong>
					    <br/>5600 Fishers Lane
					    <br/>Rockville, MD 20857
					    <br/><strong>Telephone:</strong> (301) 427-1364
					</p>
				</div><!-- /.ahrq-footer-right -->
			</div><!-- /.ahrq-footer-grid-container -->
			</div><!-- /.column -->
		</div><!-- /.second-footer -->
	</div><!-- /#ahrq-footer -->


	
	<!-- SCRIPTS -->
	
<script src="//web.archive.org/web/20180712210219js_/https://ajax.googleapis.com/ajax/libs/jquery/1.6.3/jquery.min.js" type="text/javascript"></script>
<script type="text/javascript">
if(!window.jQuery){
document.write('<script src="/cassette.axd/script/cdd67f922f9d413eaccb759182297335f87c3ff7/UI/js/jquery.js" type="text/javascript"><\/script>');
}
</script>
<script src="/web/20180712210219js_/https://www.guideline.gov/cassette.axd/script/595952c286b7fd52f0737b6f62085709be93156a/bodyJS" type="text/javascript"></script>

    
</body>
</html>
<!--
     FILE ARCHIVED ON 21:02:19 Jul 12, 2018 AND RETRIEVED FROM THE
     INTERNET ARCHIVE ON 17:57:00 Jul 15, 2018.
     JAVASCRIPT APPENDED BY WAYBACK MACHINE, COPYRIGHT INTERNET ARCHIVE.

     ALL OTHER CONTENT MAY ALSO BE PROTECTED BY COPYRIGHT (17 U.S.C.
     SECTION 108(a)(3)).
-->
<!--
playback timings (ms):
  LoadShardBlock: 1676.483 (3)
  esindex: 0.008
  captures_list: 1699.136
  CDXLines.iter: 18.343 (3)
  PetaboxLoader3.datanode: 28.072 (4)
  exclusion.robots: 0.201
  exclusion.robots.policy: 0.19
  RedisCDXSource: 0.559
  PetaboxLoader3.resolve: 2049.092 (3)
  load_resource: 510.654
-->